Clinical trial
Novel Treatment Targets For Affective Disorders Through Cross-Species Investigation of Approach/Avoidance Decision Making
NCT04325529 is registered in ClinicalTrials.gov with Mclean Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Novel Treatment Targets For Affective Disorders Through Cross-Species Investigation of Approach/Avoidance Decision Making
- Lead sponsor
- Mclean Hospital
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- January 19, 2021
- Completion date
- June 30, 2026
- Enrollment
- 148 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
major depression in remission